Back
40
Also listed as
CHJTF
OTC
Day Range
$4.17
$4.34
52-Week Range
$2.32
$5.83
Volume
1
50D / 200D Avg
$4.90
/
$4.61
Prev Close
$4.17
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 2.7 | 0.2 |
| P/B | 0.4 | 3.0 |
| ROE % | 14.1 | 3.6 |
| Net Margin % | 14.9 | 3.8 |
| Rev Growth 5Y % | 1.0 | 9.9 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2026 |
$0.00
$0.00 – $0.00
|
269.47B | 0 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2024-08-21 | N/A | $0.03 | — |
| 2024-05-27 | N/A | $0.02 | — |
| 2024-03-20 | N/A | $0.02 | — |
| 2023-12-30 | N/A | $0.03 | — |
| 2023-06-30 | N/A | $0.02 | — |
| 2023-03-31 | N/A | $0.01 | — |
| 2022-12-30 | N/A | $0.03 | — |
| 2022-06-29 | N/A | $0.03 | — |
Dividend History
7 yr streakYield
0.06%
Payout Ratio
0.75%
Growth (3Y)
2.17%
Growth (5Y)
0.12%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Oct 20, 2025 | Dec 03, 2025 | $0.06 | 2.35% |
| Jun 05, 2025 | Aug 01, 2025 | $0.05 | 3.52% |
| Nov 01, 2024 | Dec 05, 2024 | $0.08 | 5.83% |
| Jun 03, 2024 | Jul 11, 2024 | $0.07 | 4.29% |
| Sep 07, 2023 | Oct 26, 2023 | $0.07 | 4.50% |
| Jun 05, 2023 | Jul 13, 2023 | $0.06 | 3.17% |
| Sep 08, 2022 | Oct 25, 2022 | $0.05 | 2.60% |
| May 31, 2022 | Jul 07, 2022 | $0.05 | 2.17% |
| Sep 10, 2021 | Oct 25, 2021 | $0.04 | 1.79% |
| May 24, 2021 | Jun 25, 2021 | $0.05 | 1.04% |
| Sep 09, 2020 | Oct 26, 2020 | $0.02 | 1.15% |
| Jun 18, 2020 | Jul 17, 2020 | $0.08 | 1.12% |
| May 29, 2019 | Jun 28, 2019 | $0.07 | 4.22% |
Key Takeaways
Revenue grew 1.04% annually over 5 years — modest growth
Earnings declined -21.59% over the past year
ROE of 14.07% — decent returns on equity
Debt/Equity of 0.02 — conservative balance sheet
Generating 1.86B in free cash flow
P/E of 2.66 — trading at a low valuation
Growth
Revenue Growth (5Y)
1.04%
Revenue (1Y)-10.78%
Earnings (1Y)-21.59%
FCF Growth (3Y)-38.49%
Quality
Return on Equity
14.07%
ROIC13.07%
Net Margin14.92%
Op. Margin18.50%
Safety
Debt / Equity
0.02
Current Ratio2.27
Interest Coverage130.74
Valuation
P/E Ratio
2.66
Forward P/EN/A
P/B Ratio0.38
EV/EBITDA1.05
Dividend Yield0.06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -10.78% | Revenue Growth (3Y) | -6.10% |
| Earnings Growth (1Y) | -21.59% | Earnings Growth (3Y) | -18.27% |
| Revenue Growth (5Y) | 1.04% | Earnings Growth (5Y) | -2.80% |
| Profitability | |||
| Revenue (TTM) | 30.87B | Net Income (TTM) | 4.61B |
| ROE | 14.07% | ROA | 10.37% |
| Gross Margin | 69.97% | Operating Margin | 18.50% |
| Net Margin | 14.92% | Free Cash Flow (TTM) | 1.86B |
| ROIC | 13.07% | FCF Growth (3Y) | -38.49% |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 2.27 |
| Interest Coverage | 130.74 | ||
| Dividends | |||
| Dividend Yield | 0.06% | Payout Ratio | 0.75% |
| Dividend Growth (3Y) | 2.17% | Dividend Growth (5Y) | 0.12% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 2.66 | Forward P/E | N/A |
| P/B Ratio | 0.38 | P/S Ratio | 0.40 |
| PEG Ratio | -0.53 | Forward PEG | N/A |
| EV/EBITDA | 1.05 | Fwd EV/EBITDA | 0.09 |
| Forward P/S | 0.05 | Fwd Earnings Yield | N/A |
| FCF Yield | 15.17% | ||
| Market Cap | 12.24B | Enterprise Value | 5.97B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 30.87B | 34.60B | 35.01B | 34.19B | 29.62B |
| Net Income | 4.61B | 5.87B | 6.89B | 6.88B | 5.16B |
| EPS (Diluted) | 1.56 | 2.00 | 2.04 | 1.88 | 2.04 |
| Gross Profit | 21.60B | 24.40B | 22.73B | 25.47B | 21.00B |
| Operating Income | 5.71B | 7.68B | 7.58B | 7.66B | 6.49B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 44.39B | 46.28B | 41.77B | 42.50B | 35.65B |
| Total Liabilities | 10.52B | 12.39B | 11.46B | 9.71B | 8.28B |
| Shareholders' Equity | 32.26B | 33.20B | 29.77B | 31.79B | 26.48B |
| Total Debt | 507.33M | 706.90M | 621.48M | 102.76M | 358.71M |
| Cash & Equivalents | 6.78B | 12.02B | 11.65B | 9.28B | 8.65B |
| Current Assets | 21.89B | 26.74B | 23.96B | 20.34B | 18.88B |
| Current Liabilities | 9.63B | 10.18B | 10.14B | 8.84B | 7.47B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#428 of 826
Recent Activity
Exited
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Entered
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entered
Defensive Investing (Benjamin Graham)
Mar 24, 2026